Pathfinder Cell Therapy Stock Total Asset
| PFND Stock | USD 0.0001 0.00 0.00% |
Pathfinder Cell Therapy fundamentals help investors to digest information that contributes to Pathfinder Cell's financial success or failures. It also enables traders to predict the movement of Pathfinder Pink Sheet. The fundamental analysis module provides a way to measure Pathfinder Cell's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pathfinder Cell pink sheet.
Pathfinder |
Pathfinder Cell Therapy Company Total Asset Analysis
Pathfinder Cell's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Pathfinder Cell Total Asset | 106 K |
Most of Pathfinder Cell's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pathfinder Cell Therapy is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Based on the latest financial disclosure, Pathfinder Cell Therapy has a Total Asset of 106 K. This is 100.0% lower than that of the Biotechnology sector and 99.99% lower than that of the Health Care industry. The total asset for all United States stocks is 100.0% higher than that of the company.
Pathfinder Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pathfinder Cell's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Pathfinder Cell could also be used in its relative valuation, which is a method of valuing Pathfinder Cell by comparing valuation metrics of similar companies.Pathfinder Cell is currently under evaluation in total asset category among its peers.
Pathfinder Fundamentals
| Return On Asset | -8.89 | |||
| Current Valuation | 7.41 M | |||
| Shares Outstanding | 667.16 M | |||
| EBITDA | (1.67 M) | |||
| Net Income | (1.39 M) | |||
| Cash And Equivalents | 4 K | |||
| Total Debt | 5.41 M | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (963 K) | |||
| Beta | 0.14 | |||
| Market Capitalization | 2 M | |||
| Total Asset | 106 K | |||
| Retained Earnings | (19.23 M) | |||
| Working Capital | (6.76 M) | |||
| Current Asset | 9 K | |||
| Current Liabilities | 6.77 M | |||
| Net Asset | 106 K |
About Pathfinder Cell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pathfinder Cell Therapy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pathfinder Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pathfinder Cell Therapy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Pathfinder Pink Sheet
Pathfinder Cell financial ratios help investors to determine whether Pathfinder Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pathfinder with respect to the benefits of owning Pathfinder Cell security.